GCC Oncology/Cancer Drugs Market Trends 2023–2028: Outlook, Value & Key Companies

Market Size, Growth & Valuation (2023-30)

GCC Oncology/Cancer Drugs Market is projected to grow at a considerable CAGR during the forecast period, i.e., 2023-28.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

View Full Report - https://www.marknteladvisors.com/research-library/gcc-oncology-cancer-drugs-market.html

GCC Oncology/Cancer Drugs Market Structure – Segmentation & Geography

By Therapy

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Hormonal Therapy
  • Others

Based on Therapy, Targeted Therapy is anticipated to attain the highest CAGR in the forthcoming years.

 By Application

  • Breast Cancer
  • Lung Cancer
  • Kidney Cancer
  • Liver cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Skin Cancer
  • Pancreatic Cancer
  • Colorectal
  • Blood Cancer
  • Others

Breast cancer is among the leading reasons for the death of women in the region. In UAE, 1,054 new cases of breast cancer were registered in 2018. Women around the age of 40 and above are likely to develop breast cancer.

By Country

  • Saudi Arabia
  • The UAE
  • Qatar
  • Kuwait
  • Bahrain
  • Oman.

Among all the nations, the UAE is expected to be a hotspot for the demand for oncology/cancer drugs in the forecast years, owing to the massive surge in the cases of breast cancer among the female population of the country.

Key Growth Trends (2023-2028)

Growing Prevalence of Various Cancer Cases to Uplift the Oncology/Cancer Drugs Market - The GCC nations have been witnessing a massive surge in several types of cancer cases including lung cancer, breast cancer, colorectal cancer, prostate cancer, etc. The prominent factor behind the increasing cases of lung cancer in the GCC nations remains the habit of tobacco smoking among the men population. The smoking prevalence has been subsequently leading to a large number of lung cancer cases mainly in Saudi Arabia, Bahrain, and Oman. For instance, in 2020, around 6% male of Saudi Arabia were diagnosed with lung cancer, as per the World Health Organization. Thus, the growing prevalence of different types of cancers among the GCC population would facilitate the requirement for oncology/cancer drugs in the forthcoming period. 

Download Free Sample PDF - https://www.marknteladvisors.com/query/request-sample/gcc-oncology-cancer-drugs-market.html

Research Methodology

MarkNtel Advisors employs a thorough and iterative research methodology to enhance accuracy in market estimates. Our process combines bottom-up and top-down approaches, focusing on data triangulation for validation. It includes defining research objectives, selecting representative samples, and collecting data through surveys and interviews. Post-collection, we analyze and validate the data using statistical tools, ensuring reliability. Finally, we forecast market trends through predictive modeling, compiling our insights into detailed reports with charts and strategic recommendations for informed decision-making.

Competitive Analysis Framework

The GCC Oncology/Cancer Drugs industry is moderately fragmented, with key players focusing on technological advancements and strategic partnerships. A detailed competitive analysis helps businesses benchmark against industry leaders and identify growth opportunities.

Leading GCC Oncology/Cancer Drugs Companies are:

  • Hoffmann-La Roche Ltd.
  • Johnson & Johnson Middle East FZ LLC
  • Pfizer International Corporation
  • Merck Serono Middle East FZ-Ltd.
  • AbbVie Biopharmaceuticals GmbH
  • AstraZeneca Gulf FZ LLC
  • Bayer Middle East FZE
  • Amgen, Inc.
  • Astellas MENA/SSA
  • Others.

📊 Looking for a Customized Market Research Report? Visit – https://www.marknteladvisors.com/query/request-sample/gcc-oncology-cancer-drugs-market.html

(Need global, regional or country-specific data? We can tailor research to your exact requirements)

Key Questions Answered in This Report:

  1. What is the current market size of GCC Oncology/Cancer Drugs, and what growth rate is projected by 2028?
  2. Which key trends are driving GCC Oncology/Cancer Drugs market expansion in the next five years?
  3. How does market segmentation impact industry dynamics?
  4. Which geographic regions offer the highest growth potential?
  5. What are the primary challenges hindering GCC Oncology/Cancer Drugs industry growth?
  6. How do regulatory policies influence market development?
  7. What are the latest technological advancements impacting the sector?
  8. Who are the leading GCC Oncology/Cancer Drugs companies, and what are their market shares?
  9. What strategies are top competitors adopting to maintain dominance?
  10. What are the emerging niche segments with high growth potential?
  11. How do macroeconomic factors affect market performance?
  12. What are the investment opportunities for new entrants?
  13. How does pricing strategy vary across different market segments?
  14. What are the future innovation trends expected in this industry?

Other Report:

About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

Больше